Neuroleptic treatment and neurological soft signs in schizophrenic patients

Thérapie
A MechriL Gaha

Abstract

To appreciate the impact of the neuroleptic treatment on the neurological soft signs (NSS) in schizophrenic patients and to examine their relation with the treatment response based on the level of CGI-improvement. A cross-sectional study bearing on 66 schizophrenic patients: untreated patients (N = 13) and treated patients (N = 53). All patients were assessed by the Krebs et al. Neurological Soft Signs Scale and the Clinical Global Impressions (CGI). No difference has been noted concerning the NSS total score between treated and untreated schizophrenic patients. Concerning the NSS sub-scores, we have noted a significantly difference in the sensory integration sub-score. In treated patients, no correlation was found between NSS and daily dosage or duration of exposure of neuroleptic treatment, extrapyramidal symptoms and level of CGI-improvement. The excess of NSS in schizophrenic patients is independent of the neuroleptic treatment, suggesting that NSS represent a neurodevelopmental risk factor for schizophrenia.

References

Jun 1, 1991·The British Journal of Psychiatry : the Journal of Mental Science·D J KingJ L Waddington
Mar 1, 1985·The British Journal of Psychiatry : the Journal of Mental Science·T KolakowskaB M Mandelbrote
Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
Jan 1, 1970·Acta Psychiatrica Scandinavica. Supplementum·G M Simpson, J W Angus
Jan 1, 1994·The American Journal of Psychiatry·A ConvitC Evangelista
Nov 15, 1996·Biological Psychiatry·R C Smith, R P Kadewari
Feb 17, 1999·The Journal of Neuropsychiatry and Clinical Neurosciences·R C SmithA Stearns
Nov 30, 2000·Psychological Medicine·S BrowneE O'Callaghan
Jun 5, 2001·The British Journal of Psychiatry : the Journal of Mental Science·S M LawrieE C Johnstone
Aug 22, 2002·Progress in Neuro-psychopharmacology & Biological Psychiatry·Eva CeskováMiroslav Lorenc
Jun 26, 2003·Acta Psychiatrica Scandinavica·G VenkatasubramanianM S Keshavan
Jul 16, 2003·Psychiatry Research·Marco P M BoksRobert Jan van den Bosch
Jun 17, 2005·Schizophrenia Bulletin·Igor BombinRobert W Buchanan
Jul 19, 2005·Progress in Neuro-psychopharmacology & Biological Psychiatry·Levent Sevincok, Beyza Topaloglu

❮ Previous
Next ❯

Citations

Aug 23, 2016·Psychiatric Genetics·Livia CasarelliAugusto Pasini
Jun 12, 2010·European Psychiatry : the Journal of the Association of European Psychiatrists·S TumkayaN K Oguzhanoglu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here